Synthon Pharmaceuticals, Ltd.'s (Synthon)

[Guest guest]

I just put a call into this guy... awaiting his return call - he's in NY...

I have his email address.... My thought is to 'educate' him...

L

> From: SSRI medications

> Subject: Digest Number 205

>

> Chadbourne & Parke LLP

> Mark Waddell, Esq., 212/408-8044

>

>

> CHAPEL HILL, N.C.--(BUSINESS WIRE)--March 12, 2002--The Food and Drug

> Administration (FDA) has granted ``tentative approval'' to Synthon

> Pharmaceuticals, Ltd.'s (Synthon) new drug application for ASIMIA

> (paroxetine mesylate) tablets for use in the treatment of major depressive,

> obsessive compulsive, and panic disorders.

[Guest guest]

I just put a call into this guy... awaiting his return call - he's in NY...

I have his email address.... My thought is to 'educate' him...

L

> From: SSRI medications

> Subject: Digest Number 205

>

> Chadbourne & Parke LLP

> Mark Waddell, Esq., 212/408-8044

>

>

> CHAPEL HILL, N.C.--(BUSINESS WIRE)--March 12, 2002--The Food and Drug

> Administration (FDA) has granted ``tentative approval'' to Synthon

> Pharmaceuticals, Ltd.'s (Synthon) new drug application for ASIMIA

> (paroxetine mesylate) tablets for use in the treatment of major depressive,

> obsessive compulsive, and panic disorders.

[Guest guest]

Good for you Lynn!!!

Please.... let us know if you get a response from him! We're dying to know...

ML,The Avenging Angel

Please sign the petitions at:

http://www.petitiononline.com/lilpro

http://www.petitiononline.com/oky71.html

http://www.petitiononline.com/effexor

----Original Message Follows---- From: Lynn s

Reply-SSRI medications

Subject: Synthon Pharmaceuticals, Ltd.'s (Synthon) Date: Thu, 14 Mar 2002 10:16:03 -0500

Chat with friends online, try MSN Messenger: Click Here

I just put a call into this guy... awaiting his return call - he's in NY...

I have his email address.... My thought is to 'educate' him...

L

> From: SSRI medications

> Subject: Digest Number 205

>

> Chadbourne & Parke LLP

> Mark Waddell, Esq., 212/408-8044

>

>

> CHAPEL HILL, N.C.--(BUSINESS WIRE)--March 12, 2002--The Food and Drug

> Administration (FDA) has granted ``tentative approval'' to Synthon

> Pharmaceuticals, Ltd.'s (Synthon) new drug application for ASIMIA

> (paroxetine mesylate) tablets for use in the treatment of major depressive,

> obsessive compulsive, and panic disorders.

[Guest guest]

Good for you Lynn!!!

Please.... let us know if you get a response from him! We're dying to know...

ML,The Avenging Angel

Please sign the petitions at:

http://www.petitiononline.com/lilpro

http://www.petitiononline.com/oky71.html

http://www.petitiononline.com/effexor

----Original Message Follows---- From: Lynn s

Reply-SSRI medications

Subject: Synthon Pharmaceuticals, Ltd.'s (Synthon) Date: Thu, 14 Mar 2002 10:16:03 -0500

Chat with friends online, try MSN Messenger: Click Here

I just put a call into this guy... awaiting his return call - he's in NY...

I have his email address.... My thought is to 'educate' him...

L

> From: SSRI medications

> Subject: Digest Number 205

>

> Chadbourne & Parke LLP

> Mark Waddell, Esq., 212/408-8044

>

>

> CHAPEL HILL, N.C.--(BUSINESS WIRE)--March 12, 2002--The Food and Drug

> Administration (FDA) has granted ``tentative approval'' to Synthon

> Pharmaceuticals, Ltd.'s (Synthon) new drug application for ASIMIA

> (paroxetine mesylate) tablets for use in the treatment of major depressive,

> obsessive compulsive, and panic disorders.

[Guest guest]

Good for you Lynn!!!

Please.... let us know if you get a response from him! We're dying to know...

ML,The Avenging Angel

Please sign the petitions at:

http://www.petitiononline.com/lilpro

http://www.petitiononline.com/oky71.html

http://www.petitiononline.com/effexor

----Original Message Follows---- From: Lynn s

Reply-SSRI medications

Subject: Synthon Pharmaceuticals, Ltd.'s (Synthon) Date: Thu, 14 Mar 2002 10:16:03 -0500

Chat with friends online, try MSN Messenger: Click Here

I just put a call into this guy... awaiting his return call - he's in NY...

I have his email address.... My thought is to 'educate' him...

L

> From: SSRI medications

> Subject: Digest Number 205

>

> Chadbourne & Parke LLP

> Mark Waddell, Esq., 212/408-8044

>

>

> CHAPEL HILL, N.C.--(BUSINESS WIRE)--March 12, 2002--The Food and Drug

> Administration (FDA) has granted ``tentative approval'' to Synthon

> Pharmaceuticals, Ltd.'s (Synthon) new drug application for ASIMIA

> (paroxetine mesylate) tablets for use in the treatment of major depressive,

> obsessive compulsive, and panic disorders.

[Guest guest]

Good for you Lynn!!!

Please.... let us know if you get a response from him! We're dying to know...

ML,The Avenging Angel

Please sign the petitions at:

http://www.petitiononline.com/lilpro

http://www.petitiononline.com/oky71.html

http://www.petitiononline.com/effexor

----Original Message Follows---- From: Lynn s

Reply-SSRI medications

Subject: Synthon Pharmaceuticals, Ltd.'s (Synthon) Date: Thu, 14 Mar 2002 10:16:03 -0500

Chat with friends online, try MSN Messenger: Click Here

I just put a call into this guy... awaiting his return call - he's in NY...

I have his email address.... My thought is to 'educate' him...

L

> From: SSRI medications

> Subject: Digest Number 205

>

> Chadbourne & Parke LLP

> Mark Waddell, Esq., 212/408-8044

>

>

> CHAPEL HILL, N.C.--(BUSINESS WIRE)--March 12, 2002--The Food and Drug

> Administration (FDA) has granted ``tentative approval'' to Synthon

> Pharmaceuticals, Ltd.'s (Synthon) new drug application for ASIMIA

> (paroxetine mesylate) tablets for use in the treatment of major depressive,

> obsessive compulsive, and panic disorders.